The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation
Standard
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. / Kölker, Stefan; Cazorla, Angeles Garcia; Valayannopoulos, Vassili; Lund, Allan M; Burlina, Alberto B; Sykut-Cegielska, Jolanta; Wijburg, Frits A; Teles, Elisa Leão; Zeman, Jiri; Dionisi-Vici, Carlo; Barić, Ivo; Karall, Daniela; Augoustides-Savvopoulou, Persephone; Aksglaede, Lise; Arnoux, Jean-Baptiste; Avram, Paula; Baumgartner, Matthias R; Blasco-Alonso, Javier; Chabrol, Brigitte; Chakrapani, Anupam; Chapman, Kimberly; I Saladelafont, Elisenda Cortès; Couce, Maria L; de Meirleir, Linda; Dobbelaere, Dries; Dvorakova, Veronika; Furlan, Francesca; Gleich, Florian; Gradowska, Wanda; Grünewald, Stephanie; Jalan, Anil; Häberle, Johannes; Haege, Gisela; Lachmann, Robin; Laemmle, Alexander; Langereis, Eveline; de Lonlay, Pascale; Martinelli, Diego; Matsumoto, Shirou; Mühlhausen, Chris; de Baulny, Hélène Ogier; Ortez, Carlos; Peña-Quintana, Luis; Ramadža, Danijela Petković; Rodrigues, Esmeralda; Scholl-Bürgi, Sabine; Sokal, Etienne; Staufner, Christian; Summar, Marshall L; Thompson, Nicholas; Vara, Roshni; Pinera, Inmaculada Vives; Walter, John H; Williams, Monique; Burgard, Peter.
in: J INHERIT METAB DIS, Jahrgang 38, Nr. 6, 11.2015, S. 1041-1057.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation
AU - Kölker, Stefan
AU - Cazorla, Angeles Garcia
AU - Valayannopoulos, Vassili
AU - Lund, Allan M
AU - Burlina, Alberto B
AU - Sykut-Cegielska, Jolanta
AU - Wijburg, Frits A
AU - Teles, Elisa Leão
AU - Zeman, Jiri
AU - Dionisi-Vici, Carlo
AU - Barić, Ivo
AU - Karall, Daniela
AU - Augoustides-Savvopoulou, Persephone
AU - Aksglaede, Lise
AU - Arnoux, Jean-Baptiste
AU - Avram, Paula
AU - Baumgartner, Matthias R
AU - Blasco-Alonso, Javier
AU - Chabrol, Brigitte
AU - Chakrapani, Anupam
AU - Chapman, Kimberly
AU - I Saladelafont, Elisenda Cortès
AU - Couce, Maria L
AU - de Meirleir, Linda
AU - Dobbelaere, Dries
AU - Dvorakova, Veronika
AU - Furlan, Francesca
AU - Gleich, Florian
AU - Gradowska, Wanda
AU - Grünewald, Stephanie
AU - Jalan, Anil
AU - Häberle, Johannes
AU - Haege, Gisela
AU - Lachmann, Robin
AU - Laemmle, Alexander
AU - Langereis, Eveline
AU - de Lonlay, Pascale
AU - Martinelli, Diego
AU - Matsumoto, Shirou
AU - Mühlhausen, Chris
AU - de Baulny, Hélène Ogier
AU - Ortez, Carlos
AU - Peña-Quintana, Luis
AU - Ramadža, Danijela Petković
AU - Rodrigues, Esmeralda
AU - Scholl-Bürgi, Sabine
AU - Sokal, Etienne
AU - Staufner, Christian
AU - Summar, Marshall L
AU - Thompson, Nicholas
AU - Vara, Roshni
AU - Pinera, Inmaculada Vives
AU - Walter, John H
AU - Williams, Monique
AU - Burgard, Peter
PY - 2015/11
Y1 - 2015/11
N2 - BACKGROUND: The clinical presentation of patients with organic acidurias (OAD) and urea cycle disorders (UCD) is variable; symptoms are often non-specific.AIMS/METHODS: To improve the knowledge about OAD and UCD the E-IMD consortium established a web-based patient registry.RESULTS: We registered 795 patients with OAD (n = 452) and UCD (n = 343), with ornithine transcarbamylase (OTC) deficiency (n = 196), glutaric aciduria type 1 (GA1; n = 150) and methylmalonic aciduria (MMA; n = 149) being the most frequent diseases. Overall, 548 patients (69 %) were symptomatic. The majority of them (n = 463) presented with acute metabolic crisis during (n = 220) or after the newborn period (n = 243) frequently demonstrating impaired consciousness, vomiting and/or muscular hypotonia. Neonatal onset of symptoms was most frequent in argininosuccinic synthetase and lyase deficiency and carbamylphosphate 1 synthetase deficiency, unexpectedly low in male OTC deficiency, and least frequently in GA1 and female OTC deficiency. For patients with MMA, propionic aciduria (PA) and OTC deficiency (male and female), hyperammonemia was more severe in metabolic crises during than after the newborn period, whereas metabolic acidosis tended to be more severe in MMA and PA patients with late onset of symptoms. Symptomatic patients without metabolic crises (n = 94) often presented with a movement disorder, mental retardation, epilepsy and psychiatric disorders (the latter in UCD only).CONCLUSIONS: The initial presentation varies widely in OAD and UCD patients. This is a challenge for rapid diagnosis and early start of treatment. Patients with a sepsis-like neonatal crisis and those with late-onset of symptoms are both at risk of delayed or missed diagnosis.
AB - BACKGROUND: The clinical presentation of patients with organic acidurias (OAD) and urea cycle disorders (UCD) is variable; symptoms are often non-specific.AIMS/METHODS: To improve the knowledge about OAD and UCD the E-IMD consortium established a web-based patient registry.RESULTS: We registered 795 patients with OAD (n = 452) and UCD (n = 343), with ornithine transcarbamylase (OTC) deficiency (n = 196), glutaric aciduria type 1 (GA1; n = 150) and methylmalonic aciduria (MMA; n = 149) being the most frequent diseases. Overall, 548 patients (69 %) were symptomatic. The majority of them (n = 463) presented with acute metabolic crisis during (n = 220) or after the newborn period (n = 243) frequently demonstrating impaired consciousness, vomiting and/or muscular hypotonia. Neonatal onset of symptoms was most frequent in argininosuccinic synthetase and lyase deficiency and carbamylphosphate 1 synthetase deficiency, unexpectedly low in male OTC deficiency, and least frequently in GA1 and female OTC deficiency. For patients with MMA, propionic aciduria (PA) and OTC deficiency (male and female), hyperammonemia was more severe in metabolic crises during than after the newborn period, whereas metabolic acidosis tended to be more severe in MMA and PA patients with late onset of symptoms. Symptomatic patients without metabolic crises (n = 94) often presented with a movement disorder, mental retardation, epilepsy and psychiatric disorders (the latter in UCD only).CONCLUSIONS: The initial presentation varies widely in OAD and UCD patients. This is a challenge for rapid diagnosis and early start of treatment. Patients with a sepsis-like neonatal crisis and those with late-onset of symptoms are both at risk of delayed or missed diagnosis.
U2 - 10.1007/s10545-015-9839-3
DO - 10.1007/s10545-015-9839-3
M3 - SCORING: Journal article
C2 - 25875215
VL - 38
SP - 1041
EP - 1057
JO - J INHERIT METAB DIS
JF - J INHERIT METAB DIS
SN - 0141-8955
IS - 6
ER -